Related Experiment Videos
[Neurotransmitter changes in multiple sclerosis]
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|January 1, 1997
Summary
Multiple sclerosis patients show altered neurotransmitter levels in cerebrospinal fluid and blood, correlating with disease severity and neurological symptoms. These findings suggest neurotransmitter roles in multiple sclerosis pathogenesis and nervous-immune system interactions.
Area of Science:
- Neuroscience
- Biochemistry
- Immunology
Background:
- Multiple sclerosis (MS) is a chronic neurological disease.
- The interplay between the nervous and immune systems is crucial in MS pathogenesis.
- Neurotransmitter imbalances may contribute to MS-related neurological deficiencies.
Purpose of the Study:
- To investigate biochemical differences in patients with multiple sclerosis.
- To explore the relationship between biochemical markers and clinical manifestations of MS.
- To elucidate the role of neurotransmitters in the pathogenesis of multiple sclerosis.
Main Methods:
- Analysis of cerebrospinal fluid (CSF) and blood samples from multiple sclerosis patients.
- Measurement of neurotransmitter levels, including norepinephrine, glutamate, aspartate, glutamine, asparagine, and glycine.
- Correlation of biochemical findings with neurological symptoms, disease severity, and disease course.
Main Results:
- Elevated cerebrospinal fluid levels of norepinephrine, glutamate, and aspartate were observed in MS patients.
- Increased blood levels of glutamine, asparagine, and glycine were found in MS patients.
- A significant correlation was established between these biochemical indices and the character, severity, and course of neurological symptoms.
Conclusions:
- Neurotransmitter alterations are present in multiple sclerosis patients.
- These biochemical changes are linked to the clinical presentation and progression of MS.
- Neurotransmitters likely play a role in the pathogenesis of MS, particularly in the neuro-immune interactions underlying neurological deficits.